Myocardial infarction is sufficient to increase GLP‐1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity
- 23 July 2018
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 20 (12) , 2911-2918
Abstract
Myocardial infarction causes rapid impairment of left ventricular function and requires a hypercontractile response of non‐infarcted tissue areas to maintain haemodynamic stability. This compensatory adaptation is mediated by humoral, inflammatory and neuronal signals. GLP‐1 is an incretin hormone with glucoregulatory and cardioprotective capacities and is secreted in response to nutritional and inflammatory stimuli. Inactivation of GLP‐1 is caused by the ubiquitously present enzyme DPP‐4. In this study, circulating concentrations of GLP‐1 were assessed after myocardial infarction and were evaluated in the light of metabolism, left ventricular contractility and mitochondrial function. Circulating GLP‐1 concentrations were markedly increased in patients with acute myocardial infarction. Experimental myocardial infarction by permanent LAD ligation proved sufficient to increase GLP‐1 secretion in mice. This took place in a time‐dependent manner, which coincided with the capacity of DPP‐4 inhibition, by linagliptin, to augment left ventricular contractility in a GLP‐1 receptor‐dependent manner. Mechanistically, DPP‐4 inhibition increased AMPK activity and stimulated the mitochondrial respiratory capacity of non‐infarcted tissue areas. We describe a new functional relevance of inflammatory GLP‐1 secretion for left ventricular contractility during myocardial infarction.Keywords
Funding Information
- Boehringer Ingelheim
This publication has 23 references indexed in Scilit:
- Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 PathwayDiabetes, 2014
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cellsNature Medicine, 2011
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarctionEuropean Heart Journal, 2011
- Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptorMolecular and Cellular Endocrinology, 2010
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in MiceDiabetes, 2009
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent PathwaysCirculation, 2008
- Reduced Incretin Effect in Type 2 DiabetesDiabetes, 2007
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor geneNature Medicine, 1996
- Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage.Circulation, 1987